tirzepatide compounding pharmacy iowa 6-Month Plan: Just $139/month! Compounded Tirzepatide Weight Loss Program

Compounded medications are prepared under FDA oversight by licensed 503A compounding pharmacies, but the compounded formulation itself is not FDA-approved as a brand product

Whereas general obesity and central adiposity, in particular, are the primary factors responsible for the development of insulin resistance, postprandial increases in insulin secretion causes a further expansion of the adipose tissue mass, which further worsens insulin resistance

Viruses 8 , 309 (2016)

Research from the SURMOUNT trials showed that non-diabetic participants receiving tirzepatide experienced average weight loss of 20-21% of their starting body weight over 72 weeks, compared to 3-4% with placebo